cp wire

CP Wire Articles

Reversal Agent for Pradaxa, Praxbind, Now Available Nationwide

Boehringer Ingelheim announced on 5/4/18 that Praxbind (idarucizumab), a specific reversal agent for Pradaxa (dabigatran etexilate mesylate), is now stocked in 3,200 hospitals in all 50 states.... read more

Fri, 05/4/18 - 10:22 am
FDA Extends Action Date on Akcea's Inotersen, Alnylam Now in Lead

The FDA extended the PDUFA goal date of Akcea's hereditary TTR amyloidosis drug inotersen to October 6, 2018.

“The FDA has extended the review period for TEGSEDI and has assigned a new... read more

Fri, 05/4/18 - 09:54 am
MedPlast to Acquire Integer's Advanced Surgical and Orthopedics Product Lines for $600 Million

Integer Holdings Corporation (“Integer”) (NYSE:ITGR), a leading medical device outsource manufacturer, today announced that it has entered into an agreement to sell its Advanced Surgical and... read more

Thu, 05/3/18 - 06:24 pm
Australian and US Scientists Discover New Insights into Dementia and Alzheimer’s

A new research study by scientists in Australia and the US provides a possible explanation for why clinical trials of drugs reducing proteins in the brain that were thought to cause dementia and... read more

Thu, 05/3/18 - 06:11 pm
Coherus BioSciences Re-Submits BLA for Neulasta (Pegfilgrastim) Biosimilar Candidate
  • Coherus received a complete response letter from th FDA in June 2017
  • Competitors Mylan and Biocon received a CRL in October of 2017
  • Neulasta has generated $20 billion in... read more
Thu, 05/3/18 - 02:45 pm

Pages